<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E4599F86-E5D9-40AD-A427-4782E12EA8BF"><gtr:id>E4599F86-E5D9-40AD-A427-4782E12EA8BF</gtr:id><gtr:name>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C"><gtr:id>7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C</gtr:id><gtr:name>Academic Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FA143EC1-E637-4E0C-80ED-0EA8ED214038"><gtr:id>FA143EC1-E637-4E0C-80ED-0EA8ED214038</gtr:id><gtr:name>University of Leuven</gtr:name><gtr:address><gtr:line1>Oude Markt 13</gtr:line1><gtr:line2>Box 5005</gtr:line2><gtr:region>outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/00FE3D00-46A6-4EDB-9672-1565C1E10DB8"><gtr:id>00FE3D00-46A6-4EDB-9672-1565C1E10DB8</gtr:id><gtr:name>Massachusetts Institute of Technology</gtr:name><gtr:address><gtr:line1>77 Massachusetts Avenue</gtr:line1><gtr:postCode>02139</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BC66F04A-37DF-49ED-B578-A2872E12D3A2"><gtr:id>BC66F04A-37DF-49ED-B578-A2872E12D3A2</gtr:id><gtr:name>UK and International IBD Consortium</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89D5574C-AAF7-4D96-832C-C2BA623123CE"><gtr:id>89D5574C-AAF7-4D96-832C-C2BA623123CE</gtr:id><gtr:name>Eberhard Karls University Tuebingen</gtr:name><gtr:address><gtr:line1>Wilhelmstra?e 7</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E4599F86-E5D9-40AD-A427-4782E12EA8BF"><gtr:id>E4599F86-E5D9-40AD-A427-4782E12EA8BF</gtr:id><gtr:name>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C"><gtr:id>7B5B059B-D11D-4216-BAC4-CBFF7E5E3C2C</gtr:id><gtr:name>Academic Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FA143EC1-E637-4E0C-80ED-0EA8ED214038"><gtr:id>FA143EC1-E637-4E0C-80ED-0EA8ED214038</gtr:id><gtr:name>University of Leuven</gtr:name><gtr:address><gtr:line1>Oude Markt 13</gtr:line1><gtr:line2>Box 5005</gtr:line2><gtr:region>outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/00FE3D00-46A6-4EDB-9672-1565C1E10DB8"><gtr:id>00FE3D00-46A6-4EDB-9672-1565C1E10DB8</gtr:id><gtr:name>Massachusetts Institute of Technology</gtr:name><gtr:address><gtr:line1>77 Massachusetts Avenue</gtr:line1><gtr:postCode>02139</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BC66F04A-37DF-49ED-B578-A2872E12D3A2"><gtr:id>BC66F04A-37DF-49ED-B578-A2872E12D3A2</gtr:id><gtr:name>UK and International IBD Consortium</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89D5574C-AAF7-4D96-832C-C2BA623123CE"><gtr:id>89D5574C-AAF7-4D96-832C-C2BA623123CE</gtr:id><gtr:name>Eberhard Karls University Tuebingen</gtr:name><gtr:address><gtr:line1>Wilhelmstra?e 7</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7595802E-E92D-4C6E-9758-7C0AC73A3C69"><gtr:id>7595802E-E92D-4C6E-9758-7C0AC73A3C69</gtr:id><gtr:firstName>Alison</gtr:firstName><gtr:surname>Simmons</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12010%2F7"><gtr:id>64A5E48A-BAC0-4090-9A1A-355867058F52</gtr:id><gtr:title>Innate pathways in inflammatory and infectious disease</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12010/7</gtr:grantReference><gtr:abstractText>We are working on deciphering mechanisms of sensing of microbes by the immune system and how that is perturbed in diseases such as Crohn?s disease, a major inflammatory bowel disease resulting from breakdown in the normally friendly relationship between microbes present in the bowel and immune cells present in the gut wall. We use large-scale state of the art molecular approaches in primary human cells to decipher molecular pathways that are deranged in inflammatory disease in order to highlight molecules in these pathways that may be amenable to therapeutic manipulation.</gtr:abstractText><gtr:technicalSummary>Goals To define mechanisms of innate immune sensing, how defects in these processes lead to inflammation and how pathogens usurp detection by innate sensors. The HIV-1 accessory gene nef is a key HIV-1 pathogenicity factor. Our previous work showed that Nef increases the replicative capacity of HIV-1 in CD4+ T cells by triggering a signalling pathway mimicing CD4+ T cell activation with anti-CD3, and inducing key host cell factors required for viral replication (1). Proteomic analysis of CD4+ T cell signalling compartments showed that Nef positively regulates signalling by interfering with ubiquination and destruction of key CD4+ T cell signalling molecules and inhibiting Cbl activity (2). Mucosal DCs are the first cells encountered by HIV-1. They continuously sample environmental material and generate signals that determine either maintenance of immunological tolerance or activation of an adaptive immune response. Internalization of HIV-1 into DCs is mediated by dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN), important in dissemination of HIV-1 infection. To investigate the suggestion that pathogens can subvert DC-SIGN functions to avoid immune recognition we studied the signalling pathway activated by DC-SIGN triggering and showed that the signalling cascade involves activation of Rho via the guanine nucleotide exchange factor (GEF) leukaemia associated Rho GEF (LARG), important for enhancing infectious synapse formation (3). LARG has since been shown to be an essential factor for HIV-1 replication. The chronic gastrointestinal illness Crohn?s disease (CD) is thought to be due to a breakdown in immune tolerance to commensal bacteria in patients with a certain genetic background. The strongest associated CD susceptibility gene is NOD2, a cytosolic recognition receptor controlling immunity against intracellular bacteria and the inflammatory response, expressed exclusively in the monocyte lineage cells, intestinal epithelial cells and Paneth cells. We have shown that NOD2 senses intracellular bacteria and links with the antigen presentation machinery in DCs, can induce autophagy in these cells in concert with another CD susceptibility gene, ATG161L1, and is necessary for bacterial handling of MHC class II antigen presentation by human DCs. DC in CD patients are autophagy induction defective and have defects in MHC class II antigen presentation and bacterial destruction. These defects could result in abnormal clearance of bacterial components and trigger mucosal inflammation. For the first time we linked two of the strongest CD susceptibility genes within a single functional pathway (4). Most recently we have found that DCs in CD patients fail to induce miR-29 in response to NOD2 stimulation, and so do not downregulate IL-23 adequately at the end of an immune response (5). Future research plans Future work will concentrate on characterizing: (a) the function of NOD2 in relation to other PRRs and its role in intestinal epithelial cells and Paneth cells; (b) the mechanism of NOD2 mediated autophagy; (c) how post-translational modifications in microbes alter PRR sensing; (d) mechanisms of nucleic acid sensing in DCs and their implication for DC function; and on (e) genomic and chemical library screening of pathways, such as xenophagy, that are dysregulated in CD to define druggable targets. References: (1) Simmons et al. 2001 Immunity 14:763 (2) Simmons et al. 2005 Immunity 23:621 (3) Hodges et al. 2007 Nature Immunol 8: 569 (4) Cooney et al. 2010 Nature Med 16: 90 (5) Brain et al. 2010 Autophagy 3: 412.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>731000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leuven</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>miR-29 in IBD</gtr:description><gtr:id>90C0F8EF-6FE8-440D-AB6D-EAE99868FE87</gtr:id><gtr:impact>Publication in revision</gtr:impact><gtr:outcomeId>j1Bqi57Yqwp-1</gtr:outcomeId><gtr:partnerContribution>Collaborative experiments with miR-29 KO mouse generated in their lab</gtr:partnerContribution><gtr:piContribution>Defined role for miR-29 in NOD2 biology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Human Genetics</gtr:department><gtr:description>eQTL mapping CD</gtr:description><gtr:id>547F2B19-1E87-4370-A52D-33CE00B27FD2</gtr:id><gtr:impact>Will generate publications</gtr:impact><gtr:outcomeId>j9BmUcWhFQQ-1</gtr:outcomeId><gtr:partnerContribution>Design of experiment and provision data</gtr:partnerContribution><gtr:piContribution>Design of experiment, provision of biological samples and data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eberhard Karls University of Tubingen</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute for Cell Biology</gtr:department><gtr:description>Mechanism of TLR8 sensing in human cells</gtr:description><gtr:id>D0CDDAE4-B027-4B10-8279-4983E8840035</gtr:id><gtr:impact>Manuscripts in review</gtr:impact><gtr:outcomeId>cuzq4FKyZfs-1</gtr:outcomeId><gtr:partnerContribution>Provided core data</gtr:partnerContribution><gtr:piContribution>Provided core data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liverpool</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Infection and Global Health</gtr:department><gtr:description>MRC Salmonella Collaboration</gtr:description><gtr:id>0E7A0C01-27C9-4DD3-AB9D-52F4A0F613D0</gtr:id><gtr:impact>Still active, ongoing collaboration.</gtr:impact><gtr:outcomeId>56ded4943e6b93.46980249-1</gtr:outcomeId><gtr:partnerContribution>Expertise, data, support staff, analysis.</gtr:partnerContribution><gtr:piContribution>Expertise, lab facilities, data, clinical research materials, support stafff (computational biologists, clincians), analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts Institute of Technology (MIT)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Biological Engineering</gtr:department><gtr:description>Stratification of Crohn's disease</gtr:description><gtr:id>7D1BA401-B524-4CA2-A8CE-0227D9689C95</gtr:id><gtr:impact>Publications and IP in pipeline</gtr:impact><gtr:outcomeId>CRXg94b5SBK-1</gtr:outcomeId><gtr:partnerContribution>Co-supervision of computational biologist in my group</gtr:partnerContribution><gtr:piContribution>We have defined signaling paths of relevance for disease stratifcation in Crohn's</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Academic Medical Center</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Immune pathways in IBD</gtr:description><gtr:id>C8D3A147-9DCC-472F-8ACA-FE825D16DAEA</gtr:id><gtr:impact>Publications in pipeline</gtr:impact><gtr:outcomeId>EKRsfbPRsMq-1</gtr:outcomeId><gtr:partnerContribution>Provision of data</gtr:partnerContribution><gtr:piContribution>Provision of technology, culture methods, cellular material and data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>UK and International IBD Consortium</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>UK and International IBD Consortium</gtr:description><gtr:id>61F731B4-4312-45B0-9229-2E90B8183A91</gtr:id><gtr:impact>Whole genome sequence, immunochip and GWAS data for our local cohort of IBD patients. Publications resulting from this work.</gtr:impact><gtr:outcomeId>BCeHzKe6TTn-1</gtr:outcomeId><gtr:partnerContribution>As above.</gtr:partnerContribution><gtr:piContribution>Build of local IBD cohort with associated database. Identification of donors, enrolment and provision of phenotypic data and biological samples to consortia studies.
Design of specific studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Swiss Federal Institute of Technology in Lausanne (EPFL)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:description>Nanoparticle formulations for vaccine adjuvants</gtr:description><gtr:id>3C587BB6-D6AF-4072-8110-0FAD74FB279D</gtr:id><gtr:impact>Publications in pipeline</gtr:impact><gtr:outcomeId>ZWX2KkDM7Kk-1</gtr:outcomeId><gtr:partnerContribution>Provision of panels of novel nanoparticle formulations</gtr:partnerContribution><gtr:piContribution>Analysing the ability of various novel nanoparticulate formations to trigger innate immune signaling and activate the adaptive immune response in human cells</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Cellular and Molecular Physiology (CCMP)</gtr:department><gtr:description>Mechanisms of innate immune sensing</gtr:description><gtr:id>EBAECB57-C61E-4036-A770-183800B1FFA2</gtr:id><gtr:impact>Publications</gtr:impact><gtr:outcomeId>UdmjvS5Xk45-1</gtr:outcomeId><gtr:partnerContribution>Provided expertise for use of proteomic facility</gtr:partnerContribution><gtr:piContribution>Multiple proteomic experiments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Patient and Public Involvement in Gastroenterology and Mucosal Immunology Research Open Evening</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9748A654-0CD3-407F-B6BC-976723E03EF2</gtr:id><gtr:impact>A PPI event to consult and listen to public views was held on 7th September 2016. The target audience were
patients and their family members who have been diagnosed with inflammatory bowel conditions who have
attended Endoscopy and Outpatient appointments in the Oxford University Hospitals NHS Foundation Trust.
The aim of this event was to help the public become better informed about the research that is taking place in
the trust and how they can become involved. Overall the event was designed to create a more collaborative
approach between patients and the research team.</gtr:impact><gtr:outcomeId>58a3077373a226.07638627</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NOD2 mitochondrial axis in innate immunity</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>11F3D417-DC22-49A5-86C7-3844B7693C26</gtr:id><gtr:outcomeId>eACb2psZkck</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Clinical Training Fellowship (Mechanism of intracellular sensing and cross-talk between NLRs)</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>1822FA71-CACA-45DC-8DDC-DDFAEFE8086C</gtr:id><gtr:outcomeId>Kje6hKSMRrQ</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust project grant (Mechanism of NOD2 mediated autophagy)</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>3EC3CE35-04E7-4925-A4A8-CEE8D326C11C</gtr:id><gtr:outcomeId>FirtFT5kY3T</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>466000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Serine hydorlase activity in GI inflammation</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Abide Therapeutics</gtr:fundingOrg><gtr:id>CA027627-0A95-4135-BF74-1E2628174409</gtr:id><gtr:outcomeId>546481a0315191.21195388</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Clinical Training Fellowship (HIV-1 escape from innate immunity in early infection and in mucosal associated lymphoid tissue)</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>C8742C2F-2F51-4252-A713-4B6E14E3202F</gtr:id><gtr:outcomeId>U7h58nzbt6W</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Marie Curie fellowship (Information processing of commensal bacterial products by mucosal dendritic cells)</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:id>A0AD81FE-BC1A-4E8D-966C-55BC14419246</gtr:id><gtr:outcomeId>F8HS51XWXPu</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>309000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Drp1 pathway biomarker testing and stratification in Crohn's</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>AbbVie</gtr:fundingOrg><gtr:id>5CBCC5AD-C6D2-4C66-A359-81807C99095A</gtr:id><gtr:outcomeId>54648270575a16.00368748</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Oxford Biomedical Research Centre</gtr:department><gtr:description>Oxford NIHR BMRC funding (Investigation of the extent to which autophagy pathways are defective in Crohn Disease)</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Oxford University Hospitals NHS Foundation Trust</gtr:fundingOrg><gtr:id>2840803C-87B5-4EA4-9C82-6BFCEB5988D5</gtr:id><gtr:outcomeId>Tb42jiATnfJ</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Comparative gut eukaryotic microbiome in inflammatory bowel disease</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>British Council</gtr:fundingOrg><gtr:id>98F2092D-15C1-4471-BB9B-89818D8F89DD</gtr:id><gtr:outcomeId>58c7c59e15e639.73843385</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1900000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Bill and Melinda Gates foundation co-applicant with Professor Hubbell (EPFL) (Nanoparticulate delivery vaccine adjuvants and immune priming in lymphoid tissue)</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Bill and Melinda Gates Foundation</gtr:fundingOrg><gtr:id>0EF3D2C5-4818-48B2-9ED9-1F6F77088AA2</gtr:id><gtr:outcomeId>p8K7SfkbjMy</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Oxford Wellcome Clinical Training fellowship (Mechanism of NOD2 and inflammasome cross-talk)</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>881D07EE-5C68-4556-84BC-1462D8E62ECD</gtr:id><gtr:outcomeId>JgFE9ocEzQy</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>180000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Nuffield Department of Medicine</gtr:department><gtr:description>NDM studentship/Rhodes scholar (Secretory pathway function of NOD2 in intestinal mucosal cells)</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>C6E81520-CE6F-4C24-8A35-501FA6703917</gtr:id><gtr:outcomeId>mCMdxGvo4ua</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>431000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Definition of New Targets for Fibrosis in Crohn's</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>Celgene</gtr:fundingOrg><gtr:id>43C3190A-425F-4AEE-8520-37E31B170158</gtr:id><gtr:outcomeId>58c7c180e58cf2.93395985</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>IOIBD (Autophagy pathways in mucosal cells in IBD)</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>International Organization for the Study of Inflammatory Bowel Diseases (IOIBD)</gtr:fundingOrg><gtr:id>7068D60E-2B06-485B-BD71-03B4E7361910</gtr:id><gtr:outcomeId>eXBQp59fb2h</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3866000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Study of disease mechanisms in enteric fever to characterise innate and adaptive immunity in the mucosa and peripheral blood using controlled human infection</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>BA6300B1-10FA-48DA-AA2E-8DDF4679DE4F</gtr:id><gtr:outcomeId>54647ecb18d358.29331428</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>Belgium, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fondation Philippe Weiner Maurice Anspach (HIV-1 infection in gut mucosal cells)</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>Wiener-Anspach Foundation</gtr:fundingOrg><gtr:id>D4CDFE6E-50FA-466B-B12C-6500070AE5EC</gtr:id><gtr:outcomeId>eNcJkzYxCgZ</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>276000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>The Lee-Placito Medical Fund</gtr:department><gtr:description>DNA repair and innate sensing</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>3CB9C60F-477F-486D-835E-EB12C18EDF2A</gtr:id><gtr:outcomeId>FFipg6GB165</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HEFCE Senior Clinical Lecturer Award (Innate immune pathways in infectious and inflammatory disease)</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Higher Education Funding Council for England (HEFCE)</gtr:fundingOrg><gtr:id>00538301-FBCC-4689-B979-B9AE401964E0</gtr:id><gtr:outcomeId>DtSG9dPAnt2</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>Japan</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Microbes and NOD2 interaction in CD</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Ajinomoto</gtr:fundingOrg><gtr:id>8BBB49DE-ED82-4568-A795-90B056F9CCC3</gtr:id><gtr:outcomeId>546481fddffde1.38804322</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Vertex Research Grant (Identification of cellular factors involved in NOD2 mediated autophagy)</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>Vertex Pharmaceuticals</gtr:fundingOrg><gtr:id>B62377F8-ADF7-4196-91B7-855461884CA8</gtr:id><gtr:outcomeId>C1CnN37y8n1</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1399000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Genetics of IBD and disease stratification</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Eli Lilly &amp; Company Ltd</gtr:fundingOrg><gtr:id>30F47017-BD3A-4994-A4A2-D6A1D1DE32C0</gtr:id><gtr:outcomeId>54647e0313e4b4.08718452</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>750000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sir Jules Thorn Award (Defining Druggable Targets in Crohn's)</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>Sir Jules Thorn Charitable Trust</gtr:fundingOrg><gtr:id>E444A7EE-5F6B-46B9-9BAC-2D1FE4BE3845</gtr:id><gtr:outcomeId>PC4Y3K8EycC</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>267000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Oxford Biomedical Research Centre</gtr:department><gtr:description>Oxford biomedical research centre funding (Stratification of the Oxford IBD cohort)</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Oxford University Hospitals NHS Foundation Trust</gtr:fundingOrg><gtr:id>5049E6A7-D872-429B-BAD2-85254C600CD4</gtr:id><gtr:outcomeId>WBVs3weAcQh</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Research Professorship</gtr:description><gtr:end>2018-06-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>D4CEF21D-4C46-484A-B9F9-1B5E3E1C7EBF</gtr:id><gtr:outcomeId>Q4MGkBXAqz8</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>WIMM MRC studentship (Mechanisms of nucleic acid sensing and signaling in dendritic cells)</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>5BABF1F2-82A0-4349-A316-0E21E93494A1</gtr:id><gtr:outcomeId>e3W1mwZP113</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>832000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Function of NOD2 in health and in Crohn's disease</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>F4191504-B03A-44AB-A7A7-AB037E88B905</gtr:id><gtr:outcomeId>54647f7e4d0764.96454893</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>230000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UCB post-doctoral fellowship</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>UCB Pharma</gtr:fundingOrg><gtr:id>DE20A888-DB65-4AF7-AF6F-72F7C56E0395</gtr:id><gtr:outcomeId>jjdHfFGuE4c</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Method to detect or treat specific form of inflammatory lesion in Crohn's</gtr:description><gtr:grantRef>MC_UU_12010/7</gtr:grantRef><gtr:id>4C24FF36-A2C8-4E9B-9295-DE10298F6485</gtr:id><gtr:impact>N/A</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>GWSxzwKkV22</gtr:outcomeId><gtr:patentId>1204391.5</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>miR-29 as a Biomarker or Therapeutic in Crohn's</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Multiple clinical and academic managerial committees in Oxford and nationally (HIU, WIMM, TGU, NOCRI UK gastroenterology)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>11A48D40-5191-4340-A6C8-F6F9DC7160AB</gtr:id><gtr:outcomeId>546488df73cf56.93568978</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>British Society for Gastroenterology Scientific strategy committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>26BD116C-3C95-4D72-A33A-79B021B00B3B</gtr:id><gtr:outcomeId>54648859175ac0.33231819</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Academic site reviewer in Europe eg Linkoping University Sweden 2014</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>E824CE18-B216-4C1C-AEED-A5BEC20DA6B2</gtr:id><gtr:outcomeId>5464895b4f3ef2.83219293</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>National Association for Crohn's and Colitis funding committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DD769850-2B6A-43E9-A73A-A9D7C814EEF1</gtr:id><gtr:outcomeId>546487c305e8f5.47917463</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>363A7584-6B41-4961-B33B-6FC2F7082CDA</gtr:id><gtr:title>A practical solution for preserving single cells for RNA sequencing.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8cf26eefd36416f533835192fa332ef"><gtr:id>a8cf26eefd36416f533835192fa332ef</gtr:id><gtr:otherNames>Attar M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a97f0d71ab6b5.03742500</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D12BEAE6-5D5D-4B08-8DC4-0320B3F5DAB5</gtr:id><gtr:title>Circulating and Tissue-Resident CD4T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation.</gtr:title><gtr:parentPublicationTitle>Gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66a85b821d98d5e3389a53cf5bf5db99"><gtr:id>66a85b821d98d5e3389a53cf5bf5db99</gtr:id><gtr:otherNames>Hegazy AN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0016-5085</gtr:issn><gtr:outcomeId>5aaa3cdcbd84c5.97370150</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90AFA638-2300-4AE7-8EEF-9C4DFC9E95A8</gtr:id><gtr:title>Pooled sequencing of 531 genes in inflammatory bowel disease identifies an associated rare variant in BTNL2 and implicates other immune related genes.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/445a6cbea1ff0c3d67d561dda89695ca"><gtr:id>445a6cbea1ff0c3d67d561dda89695ca</gtr:id><gtr:otherNames>Prescott NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>56b34eee6193d8.41802643</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FCC46C8-AB1F-4B66-9AAE-2FD0A887CA0B</gtr:id><gtr:title>Resistance of Dynamin-related Protein 1 Oligomers to Disassembly Impairs Mitophagy, Resulting in Myocardial Inflammation and Heart Failure.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bceacc902e03fc9365d87fa48311369"><gtr:id>5bceacc902e03fc9365d87fa48311369</gtr:id><gtr:otherNames>Cahill TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>58b57823ea3259.95602249</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6527DCE-96B6-4165-A7D4-8020B9AE065F</gtr:id><gtr:title>Factors influencing success of clinical genome sequencing across a broad spectrum of disorders.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0595a7d8bf7c30b67c83c71fcc8d9e98"><gtr:id>0595a7d8bf7c30b67c83c71fcc8d9e98</gtr:id><gtr:otherNames>Taylor JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5aaa52dd417513.22290428</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C99F7F1-A981-4C3D-9EA8-1A48C3A8483F</gtr:id><gtr:title>Pattern recognition receptor mediated downregulation of microRNA-650 fine-tunes MxA expression in dendritic cells infected with influenza A virus.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/227ac5a593e836d355d93b66f49642ce"><gtr:id>227ac5a593e836d355d93b66f49642ce</gtr:id><gtr:otherNames>Pichulik T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>56b34eedb06c86.78134721</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2933BF5-84B9-4A53-9B75-12D156E29B6F</gtr:id><gtr:title>Prioritisation and network analysis of Crohn's disease susceptibility genes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a85d7da8d8044fa1d177305224b1500"><gtr:id>0a85d7da8d8044fa1d177305224b1500</gtr:id><gtr:otherNames>Muraro D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545b4ae91b7e69.94729208</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E5D2A00-71CF-4F92-A485-6A19DABBB35E</gtr:id><gtr:title>Understanding Medical Research: The Studies That Shaped Medicine</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0b86878b8cc5805ebc3705795d6722f"><gtr:id>e0b86878b8cc5805ebc3705795d6722f</gtr:id><gtr:otherNames>Goodfellow Julia M.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>9780470654484</gtr:isbn><gtr:outcomeId>5aaa504b0df959.15615564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5572AEE8-56D0-4283-AC8A-622E28EC6699</gtr:id><gtr:title>Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50e6243a98509e54910c6932cb74b8db"><gtr:id>50e6243a98509e54910c6932cb74b8db</gtr:id><gtr:otherNames>Lee JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>pm_16132_22_24035192</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCA45BD5-97FD-4F3A-9F79-8A8F03525FF0</gtr:id><gtr:title>NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7db1b373f7864413af24edeb44e89bed"><gtr:id>7db1b373f7864413af24edeb44e89bed</gtr:id><gtr:otherNames>Schwerd T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>5aaa3c89120335.47782537</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D3E60F1-B111-4432-AC01-8A90E5DFAAFC</gtr:id><gtr:title>Benzimidazoles Promote Anti-TNF Mediated Induction of Regulatory Macrophages and Enhance Therapeutic Efficacy in a Murine Model.</gtr:title><gtr:parentPublicationTitle>Journal of Crohn's &amp; colitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8601c4f5fd49f5a66f1e0f863d409609"><gtr:id>8601c4f5fd49f5a66f1e0f863d409609</gtr:id><gtr:otherNames>Wildenberg ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1873-9946</gtr:issn><gtr:outcomeId>5a97f0d6b3ff51.10003691</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51A36940-183A-4E17-938C-EA37BF8BBF40</gtr:id><gtr:title>The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/556eb43892b4e49ba6a7390bc7079397"><gtr:id>556eb43892b4e49ba6a7390bc7079397</gtr:id><gtr:otherNames>Brain O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>pm_16132_22_24054330</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C03D149-4D94-4E1F-8EFE-726B7D5DD1DD</gtr:id><gtr:title>ICG-001 affects DRP1 activity and ER stress correlative with its anti-proliferative effect.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2569552791b69cc2c0cc5b8bf3b799dd"><gtr:id>2569552791b69cc2c0cc5b8bf3b799dd</gtr:id><gtr:otherNames>Zinecker H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>5a97f0d659d624.76403181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB97C633-1551-4064-A41C-8F926A95C5CB</gtr:id><gtr:title>Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f08243406518279380370a3fd236f37"><gtr:id>4f08243406518279380370a3fd236f37</gtr:id><gtr:otherNames>Liu JZ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56b34eedddaaf5.55285427</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A54C88E-13A5-4CD9-ADA6-F0D40D4A83A6</gtr:id><gtr:title>CD90(+) Stromal Cells are Non-Professional Innate Immune Effectors of the Human Colonic Mucosa.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc84d5bfd6bb01e33e7e4cac6e581f8f"><gtr:id>dc84d5bfd6bb01e33e7e4cac6e581f8f</gtr:id><gtr:otherNames>Owens BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>pm_16132_22_24137162</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22CCA99C-118A-4739-B03F-9DA29C9617A5</gtr:id><gtr:title>Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ba4484ccc898295a012002024ec60c3"><gtr:id>8ba4484ccc898295a012002024ec60c3</gtr:id><gtr:otherNames>de Lange KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58b57c1c4e6a91.04674947</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F70F625-E8F9-49AE-8258-81B1BA98E848</gtr:id><gtr:title>Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d5b403a7f6ad6f739fef6c9fb0b8f1fd"><gtr:id>d5b403a7f6ad6f739fef6c9fb0b8f1fd</gtr:id><gtr:otherNames>Luo Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58b57897d950e9.31773306</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>671C3DAB-5114-4C0A-8F9C-428BF9FB31C7</gtr:id><gtr:title>High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f44301104351bc4e4ca5a598859ccee4"><gtr:id>f44301104351bc4e4ca5a598859ccee4</gtr:id><gtr:otherNames>Goyette P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56b34eee250452.75925211</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>935D4446-BD01-4AE6-88D0-7F36886C949A</gtr:id><gtr:title>RNA and imidazoquinolines are sensed by distinct TLR7/8 ectodomain sites resulting in functionally disparate signaling events.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f662d6e47085c874c1575259fbe6c0d8"><gtr:id>f662d6e47085c874c1575259fbe6c0d8</gtr:id><gtr:otherNames>Colak E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>545b4ae94291b1.02689656</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8356A2F7-D2D8-4354-873E-6920C72FFE17</gtr:id><gtr:title>A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bd098697bd70f44f21e158259d0b6f4"><gtr:id>1bd098697bd70f44f21e158259d0b6f4</gtr:id><gtr:otherNames>Rivas MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5aaa52dd92d1c2.35643591</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6872F144-5DBC-4FD0-85DE-C2A99BC4FD31</gtr:id><gtr:title>Snapin promotes HIV-1 transmission from dendritic cells by dampening TLR8 signaling.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e3557d868a6f9d605bbd870b65530e8"><gtr:id>4e3557d868a6f9d605bbd870b65530e8</gtr:id><gtr:otherNames>Khatamzas E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>5a97f0d625cd18.90707901</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86B4CFF6-A46A-4740-A848-91C35A532027</gtr:id><gtr:title>Functional consequences of mutations in the autophagy genes in the pathogenesis of Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Inflammatory bowel diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/556eb43892b4e49ba6a7390bc7079397"><gtr:id>556eb43892b4e49ba6a7390bc7079397</gtr:id><gtr:otherNames>Brain O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-0998</gtr:issn><gtr:outcomeId>pb13e14tLnn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEFA3ACE-9EBB-48CE-877A-B6AA1A96A0C7</gtr:id><gtr:title>Innate immune receptors for cross-presentation: The expanding role of NLRs.</gtr:title><gtr:parentPublicationTitle>Molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99ddc9a3afc3743acbf1c3033c6aa4ec"><gtr:id>99ddc9a3afc3743acbf1c3033c6aa4ec</gtr:id><gtr:otherNames>Corridoni D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0161-5890</gtr:issn><gtr:outcomeId>5a97f0d68525a9.60844540</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8533D4E9-3CC4-486E-AE36-7C3EE5F0EAE4</gtr:id><gtr:title>Emerging Mechanisms of Innate Immunity and Their Translational Potential in Inflammatory Bowel Disease.</gtr:title><gtr:parentPublicationTitle>Frontiers in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99ddc9a3afc3743acbf1c3033c6aa4ec"><gtr:id>99ddc9a3afc3743acbf1c3033c6aa4ec</gtr:id><gtr:otherNames>Corridoni D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2296-858X</gtr:issn><gtr:outcomeId>5aaa3c89566df0.62825459</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBFD8CC5-647D-479B-9C92-779267439296</gtr:id><gtr:title>RNA and Resiquimod are sensed by distinct TLR7/8 ectodomain sites resulting in functionally disparate intracellular signaling.</gtr:title><gtr:parentPublicationTitle>EMBO Molecular Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/044b3a08f8bf925bab37f0730f0dde90"><gtr:id>044b3a08f8bf925bab37f0730f0dde90</gtr:id><gtr:otherNames>Elif  Colak</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>kBF8wPZ34v9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EF05E82-45D2-48E3-BFC8-8318DDF8A176</gtr:id><gtr:title>HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fb8b35143d2c3224157d16285969e98"><gtr:id>4fb8b35143d2c3224157d16285969e98</gtr:id><gtr:otherNames>Heap GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56b34eeeabde55.84941689</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F87D23A-2053-4EBE-9BF6-05F8F63DC7CE</gtr:id><gtr:title>Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50e6243a98509e54910c6932cb74b8db"><gtr:id>50e6243a98509e54910c6932cb74b8db</gtr:id><gtr:otherNames>Lee JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5a97ef91def9e8.36388214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1CC1075-3917-404F-8968-C81643C7EE87</gtr:id><gtr:title>Guidelines for the use and interpretation of assays for monitoring autophagy.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3338e204a3c58e1fab88cb3342a71645"><gtr:id>3338e204a3c58e1fab88cb3342a71645</gtr:id><gtr:otherNames>Klionsky DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>bjkBrgsAgYp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>227A6C0A-7679-4CFA-BA47-E992D6611E40</gtr:id><gtr:title>Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4596ee70ba87c18360617a95487bcd71"><gtr:id>4596ee70ba87c18360617a95487bcd71</gtr:id><gtr:otherNames>West NR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>5a97f0d5de21d2.93529121</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0BE37909-9AE4-4BF5-BDF7-A7D6F3A92E0B</gtr:id><gtr:title>Intestinal stromal cells in mucosal immunity and homeostasis.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc84d5bfd6bb01e33e7e4cac6e581f8f"><gtr:id>dc84d5bfd6bb01e33e7e4cac6e581f8f</gtr:id><gtr:otherNames>Owens BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>D4KkaEgXEod</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D20520C6-3DA8-4AAB-B455-5704B2018FB3</gtr:id><gtr:title>Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF protein.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9743f1764abb97efe4123ec52059a045"><gtr:id>9743f1764abb97efe4123ec52059a045</gtr:id><gtr:otherNames>Bao L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a97f0d6daa365.20618594</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64D8454B-EC52-42D9-B4F2-FF08732DAE30</gtr:id><gtr:title>An integrative analysis of gene expression and molecular interaction data to identify dys-regulated sub-networks in inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a85d7da8d8044fa1d177305224b1500"><gtr:id>0a85d7da8d8044fa1d177305224b1500</gtr:id><gtr:otherNames>Muraro D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn><gtr:outcomeId>56b34eed86d483.74692138</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12010/7</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>